HOSTED PROTOTYPE

Use synthetic data only. No prescriptions are issued or medications dispensed.

PoeRx
HomeCompareZepbound vs. Mounjaro
Weight management & diabetes

Compare Zepbound vs. Mounjaro

Zepbound and Mounjaro contain tirzepatide, but they are labeled for different primary treatment goals.

MEDICAL REVIEW REQUIREDFDA and DailyMed labeling · editorial prototype

Key takeaways

  • Both are prescription tirzepatide products that act on GIP and GLP-1 receptors.
  • Zepbound is commonly discussed for chronic weight management, while Mounjaro is commonly discussed for type 2 diabetes.
  • A clinician must review contraindications, other medicines, and the intended use before recommending either product.

How they compare

EDITORIAL GUIDE
TopicZepboundtirzepatideMounjarotirzepatide
Active ingredientTirzepatideTirzepatide
Medication classGIP/GLP-1 receptor agonistGIP/GLP-1 receptor agonist
Common FDA-approved focusChronic weight management for eligible patientsType 2 diabetes management for eligible patients
AccessPrescription requiredPrescription required
DecisionWeight history, risks, current medicines, and goals must be reviewedDiabetes history, risks, current medicines, and goals must be reviewed

Primary sources

Labeling can change. Use the current FDA prescribing information and speak with a licensed clinician or pharmacist before making a treatment decision.

Zepbound FDA label Mounjaro FDA label